alumshares
VC Fund
Raleigh, United States
alumshares is a VC fund in Raleigh focused on Therapeutics and Biotechnology. alumshares connects alumni of premier research institutions with previously inaccessible investment opportunities at their Alma Mater.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries alumshares invests in
Stages alumshares invests in
Countries alumshares invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Michael McCord
|
|||
Chris Keenan
|
|||
|
Omar Flores
|
|||
Investment Focus
Industry
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Product Research 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Michael McCord
CEO
|
CEO | Total investments: 1 | Find email | |
|
Chris Keenan
Principal Software Engineer
|
Principal Software Engineer | Total investments: 0 | Find email | |
|
Omar Flores
PhD
|
PhD | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery. | $1.6M / Series A / Sep 18, 2019 | ||
| See all 2 investments → | |||
Co-Investors
BlueTree Allied Angels
2 deals together
Charleston Angel Conference
2 deals together
IAG Capital Partners
2 deals together
Next Act Fund
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does alumshares invest in?
alumshares invests primarily in Therapeutics, Biotechnology and Product Research startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact alumshares?
Public channels for alumshares include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at alumshares?
The team at alumshares includes Michael McCord (CEO), Chris Keenan (Principal Software Engineer) and Omar Flores (PhD). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
